ArticleFrontiers in pharmacology2026
Acute docosahexaenoic acid administration reduces binge-like ethanol consumption and palatable substances in C57BL/6J mice.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Excessive alcohol consumption, particularly binge drinking, is associated with cognitive impairments, emotional dysregulation and an increased vulnerability to alcohol use disorders. Emerging evidence suggests that docosahexaenoic acid (DHA), an omega-3 polyunsaturated fatty acid, modulates neuroinflammatory processes and influences dopaminergic signaling involved in reward-related behaviors. However, its acute effect on binge-like consumption remains poorly understood. The present study investigated the effects of acute oral administration of DHA-rich fish oil on binge-like drinking of ethanol in male and female C57BL/6J mice, utilizing caloric and non-caloric reinforcers to evaluate behavioral specificity. Methods: Using the Drinking-in-the-Dark (DID) paradigm, voluntary intake of ethanol, sucrose and saccharin were evaluated following DHA administration. To control potential confounds, spontaneous locomotor activity and anxiety-like behavior were assessed. Results: Acute DHA administration significantly reduced binge-like consumption of ethanol in both sexes, with a parallel reduction observed in sucrose and saccharin intake. Importantly, DHA did not alter locomotor activity or anxiety-like behaviors. Conclusion: These findings suggest that DHA exerts a rapid and robust dampening effect on binge consumption of both ethanol and natural rewards, supporting a potential role of DHA in modulating reward-driven intake. Collectively, this study highlights DHA as a promising candidate modulator of neurobehavioral processes associated with excessive and non-homeostatic consumption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.